top stories 

  • Tripura begins Covid vacc...

  • US Led The World In Expos...

  • UK's Deliveroo raises $18...

  • Washington has filled R A...

  • Varun Dhawan to join Salm...

  • WhatsApp sets WhatsApp St...

  • University students shoul...

  • Over 1,200 birds found de...

  • Bitcoin hits $40,000 for ...

Admin Reporter- POOJA1

Jan 12 2021


Pfizer compiling data to answer DCGI queries on coronavirus vaccine

Tuesday, 12 January 2021

After a three-time no-show before the expert panel on vaccines in India, US major Pfizer, which was one of the first firms to apply for a restricted emergency use approval here, says it is compiling responses to queries raised by the Indian regulator. The company spokesperson clarified that the firm is committed to engaging with the Government of India.

 

 

 

 

A Pfizer spokesperson elaborated: “Pfizer sought an opportunity to participate in the Subject Expert Committee (SEC) consultations towards an emergency use authorisation for our Covid-19 vaccine.

instagram imagesfollow us @ instagram